NFE2L2 and non-small cell lung carcinoma: CTBP2 affects the WNT in NSCLC cells [35] and furthermore activates TGF-beta signaling [36], while NFE2L2 encodes a transcription factor which has been recurrently reported being altered in NSCLC [37].